NASDAQ:TMCI | Free Cash Flow | TREACE MEDICAL CONCEPTS, INC.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2019-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31$7.24M$3.06M$4.18M
2025-12-31-$8.03M$2.4M-$10.42M
2025-03-31$4.2M$3.54M$655,000.00
2024-12-31-$4.21M$3.07M-$7.28M
2024-03-31-$7.22M$3.93M-$11.15M
2023-12-31$532,000.00$2.25M-$1.72M
2023-03-31-$17.26M$1.48M-$18.74M
2022-12-31-$5.36M$2.33M-$7.69M
2022-03-31-$7.24M$1.48M-$8.72M
2021-12-31-$3.75M$900,000.00-$4.65M
2021-03-31-$446,000.00$196,000.00-$642,000.00
2020-12-31$2.45M$88,000.00$2.36M91.94%
2020-03-31-$895,000.00$674,000.00-$1.57M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$15.97M$13.52M-$29.49M
2024-12-31-$37.17M$11.59M-$48.76M
2023-12-31-$34.58M$11.46M-$46.03M
2022-12-31-$30.65M$14.84M-$45.49M
2021-12-31-$17.19M$2.71M-$19.9M
2020-12-31-$4.49M$1.07M-$5.56M
2019-12-31-$7.67M$1.21M-$8.88M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.